Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TrazoDose: Trazodone for APAP Adherence
NCT02945644Phase 1Suspended
- Sponsor
- Louis Stokes Cleveland Department of Veterans Affairs Medical Center
- Start
- Feb 2017
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of trazodone in obstructive sleep apnea (OSA) (3 arms), sponsored by Louis Stokes Cleveland Department of Veterans Affairs Medical Center. Primary endpoint: Discontinuation rate by participant. Started Feb 2017; status: suspended.
02
Drugs
trazodone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT02945644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02945644.